Skip to content
AwardedDNKGoods

Rammeaftale om køb af Zolgensma® (onasemnogene abeparvovec)

Published
Published 24 September 2024

Overview

Formålet med rammeaftalen er at kunne forsyne sygehusapotekerne hos Amgros' interessenter med lægemidlet Zolgensma® (onasemnogene abeparvovec). Region Hovedstadens sygehusapotek foretager endvidere indkøb med henblik på videresalg Grønland og Færøerne.

Key details

Country
DNK
Status
Awarded
Category
Goods
Procedure
Direct
Published
24 September 2024
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
DKK 1
Award date
1 October 2025
Contract period
1 October 2025 → 31 July 2029
Winner
  • Novartis Healthcare A/S

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    9 March 2026

  2. Contract Notice

    24 September 2024

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Rammeaftale om køb af Zolgensma® (onasemnogene abeparvovec) — won by Novartis Healthcare A/S — Skim